Targetable Preventive Metabolites: Revealing the Pathways from Air Pollution Mixtures to Hypertension Through Integrated Exposure-Metabolomics
Full Text

Keywords

Air pollution mixtures
Hypertension
Metabolomics
Mediation analysis
Precision prevention

Categories

How to Cite

Zhu, J. (2026). Targetable Preventive Metabolites: Revealing the Pathways from Air Pollution Mixtures to Hypertension Through Integrated Exposure-Metabolomics. Journal of Public Health and Preventive Medicine, 2(9), 25-36. https://doi.org/10.64904/20260903

Abstract

Although exposure to air pollution mixes is a significant environmental risk for hypertension, it is still unclear how it causes illness through metabolic disruptions. In order to assess the possible preventative advantages of focusing on modifiable metabolites and to comprehensively uncover the metabolic mediators connecting air pollution mixes to hypertension, this work integrates exposomics and metabolomics. Individual long-term exposure to fine particulate matter (PM₂.¹), nitrogen dioxide (NO₂), and ozone (O₃) was evaluated using land use regression models and satellite data based on a prospective cohort study that included individuals without hypertension at baseline (n = 12,456). Ultra-high performance liquid chromatography-tandem mass spectrometry was used for serum untargeted metabolomics, and quantile g-computation was used to assess the cumulative impact of pollutant mixes on the prevalence of hypertension. The average causal mediation fraction of significant mediating metabolites was computed after they were screened using high-dimensional mediation analysis and causal mediation effect models with false discovery rate correction. In order to evaluate possible population-level benefits, treatments on target metabolites were further simulated using a random forest technique. There were 2,847 instances of hypertension over a median follow-up of 7.2 years. The incidence of hypertension rose by 18% for every interquartile range increase in exposure to air pollution mixtures (HR = 1.18, 95% CI: 1.12–1.24). Hexanoylcarnitine (C6-carnitine), tryptophan, and 1-stearoyl-2-arachidonoyl-sn-glycero-3-phosphocholine (PC ae C38:4) collectively mediated 32.6% (95% CI: 24.1%–41.1%) of the mixture exposure effect, independent of conventional risk factors, according to metabolomics. According to theoretical intervention analysis, about 15.3% of instances of pollution-related hypertension may be avoided if C6-carnitine levels in the population were kept below the 25th percentile. C6-carnitine and other preventable metabolites are important biological mediators of air pollution mixture-induced hypertension, partially illuminating the molecular link between environmental exposure and cardiovascular metabolic disorders. In the context of environmental health, these results offer fresh support for metabolite-targeted precision preventive techniques.

Full Text

References

[1] GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223-1249. DOI: 10.1016/S0140-6736(20)30752-2

[2] NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957-980. DOI: 10.1016/S0140-6736(21)01330-1

[3] Brook RD, Rajagopalan S, Pope CA 3rd, et al. Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation. 2010;121(21):2331-2378. DOI: 10.1161/CIR.0b013e3181dbece1

[4] Cai Y, Zhang B, Ke W, et al. Associations of Short-Term and Long-Term Exposure to Ambient Air Pollutants With Hypertension: A Systematic Review and Meta-Analysis. Hypertension. 2016;68(1):62-70. DOI: 10.1161/HYPERTENSIONAHA.116.07218

[5] Chen R, Yin P, Meng X, et al. Fine particulate air pollution and daily mortality. A nationwide analysis in 272 Chinese cities. Am J Respir Crit Care Med. 2017;196(1):73-81. DOI: 10.1164/rccm.201609-1862OC

[6] Stafoggia M, Breitner S, Hampel R, et al. Statistical Approaches to Address Multi-Pollutant Mixtures and Multiple Exposures: the State of the Science. Curr Environ Health Rep. 2017;4(4):481-490. DOI: 10.1007/s40572-017-0162-z

[7] Bobb JF, Valeri L, Claus Henn B, et al. Bayesian kernel machine regression for estimating the health effects of multi-pollutant mixtures. Biostatistics. 2015;16(3):493-508. DOI: 10.1093/biostatistics/kxu058

[8] Keil AP, Buckley JP, O'Brien KM, et al. A quantile-based g-computation approach to addressing the effects of exposure mixtures. Environ Health Perspect. 2020;128(4):47004. DOI: 10.1289/EHP5838

[9] Zhang Z, Laden F, Forman JP, et al. Long-term exposure to particulate matter and self-reported hypertension: a prospective analysis in the Nurses' Health Study. Environ Health Perspect. 2016;124(9):1414-1420. DOI: 10.1289/EHP163

[10] Wild CP. Complementing the genome with an "exposome": the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev. 2005;14(8):1847-1850. DOI: 10.1158/1055-9965.EPI-05-0456

[11] Nassan FL, Kelly RS, Kosheleva A, Koutrakis P, Vokonas PS, Lasky-Su JA, Schwartz JD. Metabolomic signatures of the long-term exposure to air pollution and temperature. Environ Health. 2021 Jan 7;20(1):3. doi: 10.1186/s12940-020-00683-x.

[12] Liang D, Moutinho JL, Golan R, Yu T, Ladva CN, Niedzwiecki M, Walker DI, Sarnat SE, Chang HH, Greenwald R, Jones DP, Russell AG, Sarnat JA. Use of high-resolution metabolomics for the identification of metabolic signals associated with traffic-related air pollution. Environ Int. 2018 Nov;120:145-154. doi: 10.1016/j.envint.2018.07.044.

[13] Nassan FL, Kelly RS, Kosheleva A, Koutrakis P, Vokonas PS, Lasky-Su JA, Schwartz JD. Metabolomic signatures of the long-term exposure to air pollution and temperature. Environ Health. 2021 Jan 7;20(1):3. doi: 10.1186/s12940-020-00683-x.

[14] Guasch-Ferré M, Toledo E, Li J, et al. Plasma metabolites from choline pathway and risk of cardiovascular disease in the PREDIMED study. J Am Heart Assoc. 2017;6(11):e006524. DOI: 10.1161/JAHA.117.006524

[15] Zheng Y, Yu B, Alexander D, et al. Metabolomics and incident hypertension among blacks: the atherosclerosis risk in communities study. Hypertension. 2013;62(2):398-403. DOI: 10.1161/HYPERTENSIONAHA.113.01166

[16] Cheng S, Rhee EP, Larson MG, et al. Metabolite profiling identifies pathways associated with metabolic risk in humans. Circulation. 2012;125(18):2222-2231. DOI: 10.1161/CIRCULATIONAHA.111.067827

[17] Cristina Menni, Sarah J. Metrustry, Robert P. Mohney, Sean Beevers, Ben Barratt, Tim D. Spector, Frank J. Kelly, Ana M. Valdes, Circulating Levels of Antioxidant Vitamins Correlate with Better Lung Function and Reduced Exposure to Ambient Pollution, American Journal of Respiratory and Critical Care Medicine, Volume 191, Issue 10, May 2015, Pages 1203–1207, https://doi.org/10.1164/rccm.201411-2059LE

[18] Valeri L, VanderWeele TJ. Mediation analysis allowing for exposure-mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macros. Psychol Methods. 2013;18(2):137-150. DOI: 10.1037/a0031034

[19] Tang H, Huang J, Lin H, Zhang X, Yang Q, Luo N, Lin M, Tian C, Wu S, Hong J, Wen J, Jiang L, Chen P, Chen X, Tang J, Zhang Y, Yi K, Tan X, Chen Y. The global burden and biomarkers of cardiovascular disease attributable to ambient particulate matter pollution. J Transl Med. 2025 Mar 22;23(1):359. doi: 10.1186/s12967-025-06375-9.

[20] Münzel T, Gori T, Al-Kindi S, et al. Effects of gaseous and solid constituents of air pollution on endothelial function. Eur Heart J. 2018;39(38):3543-3550. DOI: 10.1093/eurheartj/ehy481

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2026 Journal of Public Health and Preventive Medicine